B Cell Lymphoma

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

Recruiting
  • Lymphoma, Non-Hodgkin
  • +6 more
  • CB-010
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Aug 19, 2022

B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)

Not yet recruiting
  • B Cell Lymphoma
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2022

Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +8 more
  • New Haven, Connecticut
    Yale University
Jul 8, 2022

B Cell Lymphoma Trial in Tel-Aviv (Nivolumab Injection [Opdivo])

Recruiting
  • B Cell Lymphoma
  • Nivolumab Injection [Opdivo]
  • Tel-Aviv, Israel
    Tel-Aviv Sourasky Medicak center / BMT Unit
May 22, 2022

CB-Long-Term Safety Study (CB-LTSS)

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
  • +7 more
  • Allogeneic CAR-T therapy
  • Irvine, California
  • +3 more
Apr 14, 2022

CART Treatment, B Cell Lymphoma Trial in Tel-Aviv (Eltrombopag)

Recruiting
  • CART Treatment
  • B Cell Lymphoma
  • Tel-Aviv, Israel
    Tel-Aviv Sourasky Medicak center / BMT Unit
Apr 14, 2022

Advanced Solid Tumor, B Cell Lymphoma Trial in Brisbane (CN1)

Completed
  • Advanced Solid Tumor
  • B Cell Lymphoma
  • Brisbane, Queensland, Austria
    Mater Medical Centre
Oct 15, 2021

B Cell Lymphoma Trial in Kunming (CD19 and CD22 targeted prime CAR- T cells)

Recruiting
  • B Cell Lymphoma
  • CD19 and CD22 targeted prime CAR- T cells
  • Kunming, Yunnnan, China
    920th Hospital of Joint Logistics Support Force
Jul 30, 2021

B Cell Lymphoma Trial in United Kingdom (Varlilumab)

Active, not recruiting
  • B Cell Lymphoma
  • Manchester, United Kingdom
  • +3 more
Jul 26, 2021

B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Kunming (Anti-CD19 CAR-T Cells Injection)

Recruiting
  • B Cell Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • Anti-CD19 CAR-T Cells Injection
  • Kunming, Yunnan, China
    Kunming Yan'an Hospital
May 12, 2021

B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)

Recruiting
  • B Cell Leukemia
  • +4 more
  • CAR-ITNK cells
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 6, 2021

B Cell Lymphoma, B Cell Leukemia, Myeloma Trial in Wenzhou (CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell)

Active, not recruiting
  • B Cell Lymphoma
  • +5 more
  • CAR-CD19 T cell
  • +5 more
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Oct 5, 2020

ALL, B Cell Lymphoma, Leukemia Trial run by the NCI (Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR))

Completed
  • ALL
  • +4 more
  • Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 14, 2020

B Cell Lymphoma Trial in Guangzhou (CD19-targeting CAR T Cells infusion)

Withdrawn
  • B Cell Lymphoma
  • CD19-targeting CAR T Cells infusion
  • Guangzhou, Guangdong, China
    Central laboratory in Fuda cancer hospital
Jul 14, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

B Cell Leukemia, B Cell Lymphoma Trial in Philadelphia (CART-19)

Completed
  • B Cell Leukemia
  • B Cell Lymphoma
  • CART-19
  • Philadelphia, Pennsylvania
    CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-res
Mar 2, 2020

B Cell Lymphoma Trial in Taiyuan, Tianjin (JHL1101, Rituximab)

Terminated
  • B Cell Lymphoma
  • JHL1101
  • Rituximab
  • Taiyuan, Shanxi, China
  • +1 more
Jan 6, 2020

B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shanghai (CD20-CD19 cCAR T cells)

Unknown status
  • B Cell Lymphoma
  • B Cell Leukemia
  • CD20-CD19 cCAR T cells
  • Chengdu, China
  • +1 more
Nov 8, 2019

B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shenzhen (CD19 CARvac T cells)

Unknown status
  • B Cell Lymphoma
  • B Cell Leukemia
  • CD19 CARvac T cells
  • Chengdu, China
  • +1 more
Nov 8, 2019

Acute Lymphoblastic Leukemia, B Cell Lymphoma Trial in Wuhan (Second generation humanized CAR-T cells)

Recruiting
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Second generation humanized CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019

B Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Wuhan (Third generation CAR-T cells)

Recruiting
  • B Cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • Third generation CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019

B Cell Lymphoma Trial in Shanghai (CD20-directed CAR-T cells)

Unknown status
  • B Cell Lymphoma
  • CD20-directed CAR-T cells
  • Shanghai, China
    Shanghai Tongji Hospital, Tongji University School of Medicine
Jul 25, 2019

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Primary Cutaneous Follicle Centre Lymphoma Trial in Hefei (Autologous

Unknown status
  • Diffuse Large B Cell Lymphoma
  • +6 more
  • Autologous chimeric antigen receptor T cell transfusing agent targeting CD22
  • Hefei, Anhui, China
    PersonGen·Anke cellular therapeutics Co., Ltd
Jun 25, 2019

Acute Lymphoblastic Leukemia, B Cell Lymphoma Trial in Wuhan (Second generation CAR-T cells)

Unknown status
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Second generation CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
May 8, 2019

Acute Lymphoblastic Leukemia, B Cell Lymphoma Trial in Wuhan (Allogeneic hematological stem cell transplantation)

Unknown status
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Allogeneic hematological stem cell transplantation
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
May 8, 2019